If you are dreaming of delightful sex after prostate cancer, now it is perfect time to turn your reverie into reality. With the release of report asserting great utility of Cilia in the betterment of sexual life after prostate cancer, prostate cancer survivors can even think of improved sexual life after the gruelling treatment. As per the study conducted, Tadalis SX, an anti- erectile dysfunction (ED) drug has great potential to enhance the sexual functionality of prostate cancer survivors.
Being a first random endeavor of its type, the study was conducted on 60 patients who were treated at the Erasmus MC-Daniel Den Hoed Cancer Center of the Netherlands between the period of 1998 and 2000. All were found to be suffered of erectile dysfunction after the cancer treatment. This study was released by the International Journal of Radiation.
Prostate cancer is the most diagnosed cancer in male and can be cured in its early stage via surgery and radiation therapy or either by the unification of the two. In most cases, people who undergone prostate cancer treatment experience difficulty while erection and thus are unable of reaping maximum satisfaction during sexual intercourse.
The prime objective behind this study was to overview the potential of Tadalis SX in helping prostate cancer survivors examined with three-dimensional conformal radiation therapy (3D-CRT). And notably 48 percent survivors reported successful sexual intercourse after having consumed Tadalis SX. In addition, 67 percent people also reported remarkable improvement in the quality of their erections.